tiprankstipranks
Compass Therapeutics (CMPX)
NASDAQ:CMPX
US Market
Holding CMPX?
Track your performance easily

Compass Therapeutics (CMPX) Financial Statements

233 Followers

Compass Therapeutics Financial Overview

Compass Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.355; its P/E ratio is -4.22; Compass Therapeutics is scheduled to report earnings on March 19, 2025, and the estimated EPS forecast is $-0.10. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-$ 850.00K---
Gross Profit-$ 850.00K---
EBIT$ -10.48M$ -15.04M$ -15.39M$ -11.93M$ -13.34M
EBITDA$ -10.29M$ -14.58M$ -14.93M$ -11.46M$ -12.86M
Net Income Common Stockholders$ -10.48M$ -13.08M$ -13.41M$ -9.96M$ -11.28M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 135.40M$ 146.23M$ 152.46M$ 163.70M$ 168.75M
Total Assets$ 149.15M$ 155.61M$ 156.88M$ 170.04M$ 179.18M
Total Debt$ 6.88M$ 1.09M$ 1.73M$ 2.04M$ 2.34M
Net Debt$ -128.53M$ -145.14M$ -150.73M$ -161.66M$ -166.41M
Total Liabilities$ 10.75M$ 9.51M$ 8.34M$ 9.99M$ 10.89M
Stockholders Equity$ 138.40M$ 146.10M$ 148.54M$ 160.04M$ 168.29M
Cash Flow-
Free Cash Flow$ -11.10M$ -10.75M$ -12.36M$ -5.93M$ -10.12M
Operating Cash Flow$ -11.05M$ -10.75M$ -12.35M$ -5.92M$ -10.11M
Investing Cash Flow$ 29.02M$ 6.48M$ 6.31M$ 17.05M$ -667.00K
Financing Cash Flow$ -2.00K$ 1.00K$ -158.00K$ 21.00K$ 3.03M
Currency in USD

Compass Therapeutics Earnings and Revenue History

Compass Therapeutics Debt to Assets

Compass Therapeutics Cash Flow

Compass Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis